The presented analysis of both bulk- and scRNAseq data confirms that these double-positive sPitNETs are the ones that express high levels of GIPR and expression of this gene distinguishes the tumor cells of this subtype from normal pituitary somatotrophs, which are GIPR-negative. Here, GIPR is linked to neoplasm.